Literature DB >> 10619925

Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients.

S A Teles1, R M Martins, B Vanderborght, L Stuyver, A M Gaspar, C F Yoshida.   

Abstract

There are no data concerning the genotypic analysis of hepatitis B virus (HBV) infection in Brazilian dialysis centers. Serum samples from all hemodialysis patients (n = 282) in Goiânia City, Central Brazil, were tested for hepatitis B surface antigen (HBsAg). An overall prevalence of 12.0% was found, ranging from 0 to 33.3% depending on dialysis centers. Positive samples (n = 34) were submitted to serological subtyping by monoclonal ELISA and HBV DNA detection by polymerase chain reaction (PCR). Among 30 PCR-positive samples, 26 were genotyped by use of the line probe assay technology (INNO-LiPA HBV, Innogenetics, Gent, Belgium). HBV genotypes A (50. 0%) and D (46.2%) were the most frequently found whereas genotype F (3.8%) was rare in this population. Serological subtypes adw2 (44. 1%) and ayw3 (41.2%) were dominant. By contrast, adw4 and ayw2 were found at a low frequency (2.9%). A correlation was observed in the distribution of genotypes and subtypes by dialysis center. Genotype D and subtype ayw3 were predominant in 2 hemodialysis centers whereas genotype A and subtype adw2 were predominant in the others. The findings of high HBsAg prevalence rates restricted to certain dialysis centers and the data obtained through genotyping and serological subtyping suggest HBV nosocomial transmission in these hemodialysis centers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619925     DOI: 10.1046/j.1525-1594.1999.06310.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  11 in total

1.  Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff.

Authors:  S A Tele; R M Martins; C L Lopes; M A dos Santos Carneiro; K P Souza; C F Yoshida
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H.

Authors:  Cosme Alvarado-Esquivel; Erwin Sablon; Carlos-Jesús Conde-González; Luis Juárez-Figueroa; Lilia Ruiz-Maya; Sergio Aguilar-Benavides
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

3.  Hepatitis B viral infection in maintenance hemodialysis patients: a three year follow-up.

Authors:  Ya-Li Cao; Shi-Xiang Wang; Zuo-Min Zhu
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

4.  Hepatitis B virus genotypes and precore and core mutants in Brazilian patients.

Authors:  Roberta Sitnik; João Renato Rebello Pinho; Dennis Armando Bertolini; Antonio Plinio Bernardini; Luiz Caetano Da Silva; Flair José Carrilho
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  The accelerated hepatitis B virus vaccination schedule among hemodialysis patients, does it work? A randomized controlled trial.

Authors:  Mahmoud Hamada Imam
Journal:  J Nephrol       Date:  2017-10-03       Impact factor: 3.902

6.  An in-house real-time polymerase chain reaction: standardisation and comparison with the Cobas Amplicor HBV monitor and Cobas AmpliPrep/Cobas TaqMan HBV tests for the quantification of hepatitis B virus DNA.

Authors:  Ana Paula de Torres Santos; José Eduardo Levi; Marcilio Figueiredo Lemos; Samira Julien Calux; Isabel Takano Oba; Regina Célia Moreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-02       Impact factor: 2.743

7.  Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil.

Authors:  Priscila A Tonetto; Neiva S L Gonçales; Viviane C Fais; Aline G Vigani; Eduardo S L Gonçales; Adriana Feltrin; Fernando L Gonçales
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

8.  Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates.

Authors:  Francisco C A Mello; Francisco J D Souto; Leticia C Nabuco; Cristiane A Villela-Nogueira; Henrique Sergio M Coelho; Helena Cristina F Franz; Joao Carlos P Saraiva; Helaine A Virgolino; Ana Rita C Motta-Castro; Mabel M M Melo; Regina M B Martins; Selma A Gomes
Journal:  BMC Microbiol       Date:  2007-11-23       Impact factor: 3.605

9.  Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology.

Authors:  Flair J Carrilho; Cleusa R Moraes; João R R Pinho; Isabel M V G C Mello; Dennis A Bertolini; Marcílio F Lemos; Regina C Moreira; Leda C Bassit; Rita A Cardoso; Gabriela Ribeiro-dos-Santos; Luiz C Da Silva
Journal:  BMC Public Health       Date:  2004-04-27       Impact factor: 3.295

10.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.